Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MARC S SABATINE

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1346298668
CMS profile
333691
Location
BOSTON, MA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$1,353,717.10

60 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Merck Sharp & Dohme LLC $1,298,565.69 16
AstraZeneca UK Limited $20,671.86 16
AstraZeneca Pharmaceuticals LP $14,677.99 12
Amgen Inc. $13,776.56 14
Boehringer Ingelheim International GmbH $6,025.00 2

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

60 matching records · $1,353,717.10 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 60 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 60.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Merck Sharp & Dohme LLC $333.0412/26/2024 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261186254294 CMS
Merck Sharp & Dohme LLC $46.0012/26/2024 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261186254314 CMS
Merck Sharp & Dohme LLC $495,699.1011/27/2024 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261186254300 CMS
Merck Sharp & Dohme LLC $739,102.7711/27/2024 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261186254302 CMS
Merck Sharp & Dohme LLC $13,206.7011/27/2024 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261186254306 CMS
Merck Sharp & Dohme LLC $1,168.2511/25/2024 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261186254292 CMS
Merck Sharp & Dohme LLC $4,873.9011/25/2024 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261186254298 CMS
Merck Sharp & Dohme LLC $9,955.4011/25/2024 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261186254304 CMS
Amgen Inc. $48.0011/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261111694668 CMS
Amgen Inc. $48.0011/17/2024 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261155805560 CMS
Amgen Inc. $15.0011/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261117672449 CMS
Amgen Inc. $15.0011/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261117672451 CMS
Amgen Inc. $2,262.0010/30/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261117672445 CMS
Boehringer Ingelheim International GmbH $1,600.0009/27/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261117972391 CMS
Boehringer Ingelheim International GmbH $4,425.0009/27/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261117972393 CMS
Merck Sharp & Dohme LLC $18.3109/27/2024 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261186254310 CMS
Merck Sharp & Dohme LLC $811.6809/27/2024 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261186254318 CMS
AstraZeneca Pharmaceuticals LP $12,000.0009/02/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110547348 CMS
Amgen Inc. $16.2408/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261111694666 CMS
Amgen Inc. $54.0408/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261117672447 CMS
Merck Sharp & Dohme LLC $71.9008/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141729880 CMS
Amgen Inc. $3,016.0008/19/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261111694662 CMS
Amgen Inc. $140.0008/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261111694660 CMS
AstraZeneca Pharmaceuticals LP $15.3907/26/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110552698 CMS
AstraZeneca Pharmaceuticals LP $101.6507/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110553268 CMS
AstraZeneca Pharmaceuticals LP $135.0006/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110532697 CMS
AstraZeneca Pharmaceuticals LP $78.9306/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110541983 CMS
AstraZeneca Pharmaceuticals LP $167.5006/25/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110542983 CMS
AstraZeneca Pharmaceuticals LP $167.5006/25/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110546549 CMS
AstraZeneca Pharmaceuticals LP $1,240.3406/25/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110546931 CMS
AstraZeneca Pharmaceuticals LP $96.0306/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110549422 CMS
AstraZeneca Pharmaceuticals LP $104.6906/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110550026 CMS
AstraZeneca Pharmaceuticals LP $69.9106/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110555140 CMS
AstraZeneca Pharmaceuticals LP $501.0506/25/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110555160 CMS
Amgen Inc. $2,639.0005/10/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261117672443 CMS
Merck Sharp & Dohme LLC $38.7205/05/2024 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261186254312 CMS
Merck Sharp & Dohme LLC $409.7305/05/2024 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261186254316 CMS
Amgen Inc. $2,262.0004/24/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261117672441 CMS
AstraZeneca UK Limited $12,750.0004/18/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110542439 CMS
Merck Sharp & Dohme LLC $4,332.0004/17/2024 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261186254296 CMS
Merck Sharp & Dohme LLC $28,373.1904/17/2024 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261186254308 CMS
Amgen Inc. $45.5404/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261111694664 CMS
Amgen Inc. $48.9404/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261117672453 CMS
Merck Sharp & Dohme LLC $125.0004/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141553639 CMS
Amgen Inc. $3,166.8004/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261111694658 CMS
AstraZeneca UK Limited $81.8303/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110534688 CMS
AstraZeneca UK Limited $46.0203/22/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110538133 CMS
AstraZeneca UK Limited $53.8003/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110552956 CMS
AstraZeneca UK Limited $159.8402/22/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110531011 CMS
AstraZeneca UK Limited $26.3702/22/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110536674 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $61,161.60 41
PY2020 $50,340.35 30
PY2021 $40,435.00 20
PY2022 $85,710.92 34
PY2023 $1,126,879.96 14
PY2024 $1,353,717.10 60
PY2025 $1,144,069.53 32

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
MARC S SABATINE, NPI 1346298668. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1346298668.
APA 7
IndustryPayments. (2026). MARC S SABATINE, NPI 1346298668 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1346298668
Bluebook
MARC S SABATINE, NPI 1346298668, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1346298668.

Source: Centers for Medicare & Medicaid Services, Open Payments.